NEW YORK (GenomeWeb News) – Abbott Laboratories today reported that its fourth quarter 2013 molecular diagnostics sales were flat year over year as its overall diagnostics sales increased 6 percent.

The firm posted MDx sales of $131 million for the quarter, flat with Q4 2012. It said that foreign exchange trimmed nearly 1 percent off its MDx revenues for the quarter. However, its international MDx sales were up around 10 percent on an operational basis, driven by "continued strong growth in infectious disease testing, particularly in emerging markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.